Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study Scientific literature GHDx Entry last modified on: Apr 14, 2022
Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008-2012 National Health Interview Survey Scientific literature GHDx Entry last modified on: Apr 14, 2022
HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland Scientific literature GHDx Entry last modified on: Mar 14, 2022
Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany Scientific literature GHDx Entry last modified on: Mar 14, 2022
[Current situation of HPV vaccination in Germany] Aktueller Stand der HPV-Impfung in Deutschland Scientific literature GHDx Entry last modified on: Mar 14, 2022
The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy Scientific literature GHDx Entry last modified on: May 30, 2020
Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States Scientific literature GHDx Entry last modified on: Apr 14, 2022
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Use of health care reimbursement data to estimate vaccination coverage in France: Example of hepatitis B, meningitis C, and human papillomavirus vaccination Scientific literature GHDx Entry last modified on: Mar 14, 2022
Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis Scientific literature GHDx Entry last modified on: May 30, 2020
Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer Scientific literature GHDx Entry last modified on: May 30, 2020
Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States Scientific literature GHDx Entry last modified on: Jan 31, 2023
Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators Scientific literature GHDx Entry last modified on: Mar 14, 2022
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands Scientific literature GHDx Entry last modified on: Jan 31, 2023
Estimating human papillomavirus vaccination coverage among young women in Victoria and reasons for non-vaccination Scientific literature GHDx Entry last modified on: Jan 31, 2024
Papillomavirus and cancers: should we extend vaccination to boys in France? Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region Scientific literature GHDx Entry last modified on: Jan 31, 2024
Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide Scientific literature GHDx Entry last modified on: Mar 14, 2022
Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand Scientific literature GHDx Entry last modified on: Jan 31, 2023
Factors influencing uptake of HPV vaccination among girls in Germany Scientific literature GHDx Entry last modified on: Mar 14, 2022
Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey, 2013 Scientific literature GHDx Entry last modified on: Mar 14, 2022
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany Scientific literature GHDx Entry last modified on: May 30, 2020
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Present status of human papillomavirus vaccine development and implementation Scientific literature GHDx Entry last modified on: Mar 14, 2022
United States National Health and Nutrition Examination Survey 2007-2008 Survey: Cross-sectional - Exam - Household - Individual - Interview - Nationally representative GHDx Entry last modified on: Dec 14, 2023
Malaysia Health Indicators 2013 Report: Discharge - Inpatient - Outpatient - Subnationally representative GHDx Entry last modified on: Sep 15, 2021
Norway Immunization Registry 2007 SYSVAK Administrative data: Subnationally representative GHDx Entry last modified on: Aug 5, 2021
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model Scientific literature GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan Scientific literature GHDx Entry last modified on: Jan 31, 2023
Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland Scientific literature GHDx Entry last modified on: Mar 14, 2022
Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review Scientific literature GHDx Entry last modified on: Mar 14, 2022
China Lot Release of Vaccines 2007-2018 Administrative data GHDx Entry last modified on: Apr 12, 2021
Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents Scientific literature GHDx Entry last modified on: Jan 31, 2024
Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007-2014 Scientific literature GHDx Entry last modified on: Mar 14, 2022
Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark Scientific literature GHDx Entry last modified on: Jan 31, 2023
Adolescent vaccine co-administration and coverage in New York City: 2007-2013 Scientific literature GHDx Entry last modified on: Jan 31, 2024
Marshall Islands Ministry of Health Annual Report 2009 Report: Financial - Inpatient - Operational - Outpatient GHDx Entry last modified on: Sep 3, 2021
Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study Scientific literature GHDx Entry last modified on: Jan 31, 2023
Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents Scientific literature GHDx Entry last modified on: Apr 14, 2022
Australia Immunisation Coverage Annual Report 2016 Annual Immunisation Coverage Report 2016 Report: Subnationally representative GHDx Entry last modified on: Aug 6, 2021
Socioeconomic predictors of human papillomavirus vaccination in Danish men - A nationwide study Scientific literature GHDx Entry last modified on: Mar 14, 2022
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States Scientific literature GHDx Entry last modified on: May 30, 2020
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis Scientific literature GHDx Entry last modified on: May 30, 2020
Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France Scientific literature GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium Scientific literature GHDx Entry last modified on: Jan 31, 2023
Marshall Islands Ministry of Health Annual Report 2010 Ministry of Health Republic of the Marshall Islands "Kumiti Ejmuur" Annual Report FY 2010 Report: Discharge - Epi surveillance - Financial - Inpatient - Operational - Outpatient GHDx Entry last modified on: Sep 3, 2021
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway Scientific literature GHDx Entry last modified on: Jan 31, 2023